Targeting intratumoral androgens: statins and beyond Tekijä Michael T. Schweizer, Evan Y. Yu

Hae kokoteksti

The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions Tekijä Evan Y Yu, William K Oh

Hae kokoteksti

Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate ca... Tekijä Michael Lai, Evan Y Yu, Michael T Schweizer, Darien E Reed-Perino

Hae kokoteksti

Hormone levels following surgical and medical castration: defining optimal androgen suppression Tekijä Michael T Schweizer, Michael L Hancock, Robert H Getzenberg, Evan Y Yu

Hae kokoteksti

Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies. Tekijä Laura S Graham, Bruce Montgomery, Heather H Cheng, Evan Y Yu, Peter S Nelson, Colin Pritchard, Stephanie Erickson, Ajjai Alva, Michael T Schweizer

Hae kokoteksti

Whole-Body [¹⁸F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN... Tekijä Mark Muzi, Finbarr O’Sullivan, Timothy G. Perk, John P. Muzi, David A. Mankoff, Robert Jeraj, Fenghai Duan, Evan Y. Yu

Hae kokoteksti

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Tekijä Franklin C. Lee, William Harris, Heather H. Cheng, Jaideep Shenoi, Song Zhao, Junfeng Wang, Thomas Champion, Jason Izard, John L. Gore, Michael Porter, Evan Y. Yu, Jonathan L. Wright

Hae kokoteksti

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer Tekijä Alexander S. Carlson, Rigo I. Acevedo, Daniel M. Lim, Roman Gulati, Agnes Gawne, Alexandra O. Sokolova, Heather H. Cheng, Peter S. Nelson, R. Bruce Montgomery, Evan Y. Yu, Michael T. Schweizer, Alvaro Galli

Hae kokoteksti

Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. Tekijä Michael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, Roman Gulati, Heather H Cheng, Jessica L Maes, Ruth F Dumpit, Peter S Nelson, Bruce Montgomery, Jeannine S McCune, Stephen R Plymate, Evan Y Yu

Hae kokoteksti

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. Tekijä Michael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, Roman Gulati, Heather H Cheng, Jessica L Maes, Ruth F Dumpit, Peter S Nelson, Bruce Montgomery, Jeannine S McCune, Stephen R Plymate, Evan Y Yu

Hae kokoteksti

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) Tekijä Holden T Maecker, Lawrence Fong, Leonard D’Amico, Martin Cheever, Leonard Appleman, Steven P Fling, Nirasha Ramchurren, Russell Szmulewitz, Omer Kucuk, Paul Monk, Caroline Duault, Russell K Pachynski, Lauren Harshman, Rhonda L Bitting, Frederick Millard, John D Seigne, Bruce Hess, Andreanne Lacroix, Judith C Kaiser, Michel Morre, Anne Grégoire, Evan Y Yu

Hae kokoteksti

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database Tekijä Gabriella Del Bene, Fabio Calabrò, Diana Giannarelli, Elizabeth R. Plimack, Lauren C. Harshman, Evan Y. Yu, Simon J. Crabb, Sumanta Kumar Pal, Ajjai S. Alva, Thomas Powles, Ugo De Giorgi, Neeraj Agarwal, Aristotelis Bamias, Sylvain Ladoire, Andrea Necchi, Ulka N. Vaishampayan, Günter Niegisch, Joaquim Bellmunt, Jack Baniel, Matthew D. Galsky, Cora N. Sternberg

Hae kokoteksti

A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy Tekijä Matthew D. Greer, MD, Stephanie K. Schaub, MD, Stephen R. Bowen, PhD, Jay J. Liao, MD, Kenneth Russell, MD, Jonathan J. Chen, MD, Emily S. Weg, MD, Juergen Meyer, PhD, Tristan Alving, George R. Schade, MD, John L. Gore, MD, Sarah P. Psutka, MD, MS, Robert B. Montgomery, MD, Michael Schweizer, MD, Evan Y. Yu, MD, Petros Grivas, MD, PhD, Jonathan L. Wright, MD, MS, FACS, Jing Zeng, MD

Hae kokoteksti

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates Tekijä Azra Ajkunic, Erolcan Sayar, Martine P. Roudier, Radhika A. Patel, Ilsa M. Coleman, Navonil De Sarkar, Brian Hanratty, Mohamed Adil, Jimmy Zhao, Samir Zaidi, Lawrence D. True, Jamie M. Sperger, Heather H. Cheng, Evan Y. Yu, Robert B. Montgomery, Jessica E. Hawley, Gavin Ha, Thomas Persse, Patricia Galipeau, John K. Lee, Stephanie A. Harmon, Eva Corey, Joshua M. Lang, Charles L. Sawyers, Colm Morrissey, Michael T. Schweizer, Roman Gulati, Peter S. Nelson, Michael C. Haffner

Hae kokoteksti

Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Tekijä Tessa Ladner, Anna J. Black, Homayoun Zargar, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Michael S. Cookson, Niels-Erik Jacobsen, Adrian S. Fairey, Colin P. N. Dinney, Maria C. Mir, Laura-Maria Krabbe, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Andrew J. Stephenson, Jay B. Shah, Siamak Daneshmand, Kamran Zargar-Shoshtari, Philippe E. Spiess, Laura S. Mertens, Bas W. G. van Rhijn, Petros Grivas, Wassim Kassouf, Marc A. Dall’Era, Srikala S. Sridhar, Jonathan S. McGrath, Jonathan Aning, Shahrokh F. Shariat, Trinity J. Bivalacqua, Scott A. North, Daniel A. Barocas, Yair Lotan, Peter C. Black

Hae kokoteksti